Correlation Between Bristol Myers and DOW JONES

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and DOW JONES at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and DOW JONES into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and DOW JONES EQUITY, you can compare the effects of market volatilities on Bristol Myers and DOW JONES and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of DOW JONES. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and DOW JONES.

Diversification Opportunities for Bristol Myers and DOW JONES

-0.48

Correlation Coefficient

Bristol Myers  DOW JONES

Very good diversification

The 3 months correlation between Bristol and DOW is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and DOW JONES EQUITY in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DOW JONES EQUITY and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with DOW JONES. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DOW JONES EQUITY has no effect on the direction of Bristol Myers i.e., Bristol Myers and DOW JONES go up and down completely randomly.

Pair Corralation between Bristol Myers and DOW JONES

Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 2.07 times more return on investment than DOW JONES. However, Bristol Myers is 2.07 times more volatile than DOW JONES EQUITY. It trades about 0.0 of its potential returns per unit of risk. DOW JONES EQUITY is currently generating about -0.29 per unit of risk. If you would invest  100,555  in Bristol Myers Squibb on September 20, 2024 and sell it today you would lose (666.00) from holding Bristol Myers Squibb or give up 0.66% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Bristol Myers Squibb  vs.  DOW JONES EQUITY

Pair Trading with Bristol Myers and DOW JONES

The main advantage of trading using opposite Bristol Myers and DOW JONES positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, DOW JONES can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DOW JONES will offset losses from the drop in DOW JONES's long position.

The idea behind Bristol Myers Squibb and DOW JONES EQUITY pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.